| Autor: |
Benner SE; University of North Carolina at Chapel Hill, USA., Lippman SM, Hong WK |
| Jazyk: |
angličtina |
| Zdroj: |
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 1995 Mar; Vol. 9 (3), pp. 205-10; discussion 210, 213-4, 216. |
| Abstrakt: |
Clinical trials have suggested that retinoid chemoprevention prevents the development of second primary tumors following head and neck or non-small-cell lung cancer. The findings of these initial studies are now being evaluated in large multi-institution chemoprevention trials. If successful, these ongoing trials will establish the clinical role of retinoids in lung cancer prevention. The findings of these trials may also lead to strategies for primary lung cancer prevention. Until the results of these studies become available, however, lung cancer chemoprevention remains an experimental approach. The recent unexpected findings of increased lung cancer incidence in a beta-carotene study in Finnish smokers stresses the importance of establishing the efficacy of chemoprevention agents in carefully conducted clinical trials. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
